Alan Osborne Trounson is a scientist from Australia who studies embryology and stem cells. His research has improved the success rates of in vitro fertilization, or IVF. IVF is a medical procedure in which scientists fertilize an egg cell with sperm outside of the body, often in a laboratory petri dish, then transfer the fertilized egg to a woman’s uterus to start pregnancy. Trounson also researched embryonic stem cells, or stem cells collected from embryos, and their potential for treating injuries and diseases. Additionally, Trounson led the Californian Institute for Regenerative Medicine, or CIRM, one of the largest agencies to fund stem cell research in California, from 2007 to 2014. Over the course of his career, Trounson developed several techniques that improved the effectiveness of IVF, including fertility treatments and cryopreservation, and supported stem cell research as a scientist and administrator.
Laparoscopic tubal sterilization is a set of surgical techniques that use laparoscopy to render people with female reproductive systems sterile, or unable to reproduce. In a laparoscopy, a surgeon uses small incisions in the abdomen to feed in a camera or other viewing tool that aids in diagnosing internal medical issues or treating those issues via surgery. To sterilize a patient, the surgeon uses a camera with attached surgical tools to guide the procedure and interfere with the fallopian tubes to stop the passage of an egg. Laparoscopic sterilization was developed as an alternative to surgical sterilization that requires larger incisions to open the abdomen to access the fallopian tubes, which can pose a greater risk of complications. Due to decades of technical development, laparoscopic tubal sterilization allows people with female reproductive systems to control their fertility more safely and less invasively than with other surgical methods.
In December of 2016, Margus Punab and colleagues published “Causes of Male Infertility: A 9-year Prospective Monocentre Study on 1737 Patients with Reduced Total Sperm Counts,” hereafter “Male Infertility,” in the journal Human Reproduction. The study examines the main causes of severe male factor infertility, or SMF infertility, which occurs when a male’s semen has a very low number of healthy sperm cells or contains atypically low levels of sperm cells. In “Male Infertility,” the authors determine the primary cause of SMF infertility in forty percent of their participants, and among those participants, they found that the primary causes of SMF infertility were varicoceles, or enlarged veins within the loose bag of skin holding the testicles. The authors did not determine the cause of SMF infertility in the remaining sixty percent of the cases, noting a gap in the current understanding of the causes of SMF infertility. “Male Infertility” was one of the first large-scale studies to reveal certain underlying causes of SMF infertility, and its conclusions have allowed researchers to investigate fertility solutions for male patients who would otherwise not be able to reproduce.
In 2020, Osamah Batiha and colleagues published their article “Impact of COVID-19 and Other Viruses on Reproductive Health,'' hereafter “Impact of COVID-19,” in the journal Andrologia. The article is a literature review that encompasses various studies on how coronavirus disease 2019, or COVID-19, impacts male fertility and pregnancy. COVID-19 is a viral disease that primarily infects the respiratory system and causes infection through the virus severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2. The researchers published “Impact of COVID-19” during the middle of the COVID-19 pandemic, which was a time of global panic and uncertainty. “Impact of COVID-19” was one of the first studies to examine the potential effects of COVID-19 on male fertility and elicited discussion within the scientific community regarding the necessary safety precautions to take during viral pandemics.
In 1924, John Burdon Sanderson Haldane, aka JBS Haldane, published Daedalus; or Science and The Future, hereafter Daedalus, which was a written version of a lecture that he gave in 1923. In his book, Haldane offers his personal predictions about what science will be able to achieve by the year 2073. He proposes that scientists will be able to perform ectogenesis, which he defines as the gestation of an organism in an artificial environment. He argues that the development of ectogenesis will help improve the human species by facilitating the selective breeding of individuals with desirable traits. Haldane’s vision of ectogenesis in Daedalus foreshadowed in vitro fertilization, or IVF, an assisted-reproductive technology in which scientists fertilize an egg in a laboratory dish, then implant the resulting embryo into a woman’s uterus where it then develops into a fetus. As of 2025, physicians deliver over 500,000 infants per year who were conceived using assisted-reproductive technologies such as IVF. Haldane’s concept of ectogenesis as he described it in Daedalus inspired both supportive and critical responses among readers and has shaped discussions about reproductive technologies down to the present day.
In 1970, Shulamith Firestone, a self-described radical feminist and writer, published The Dialectic of Sex: The Case for Feminist Revolution, hereafter The Dialectic of Sex. In the book, she argues for the replacement of natural reproduction with artificial reproduction in order to provide women liberation from their reproductive biology. Firestone envisions a day when scientific technology will enable children to be conceived and grown completely outside of a woman’s uterus, what scientists call ectogenesis. At the time of publication, the technology to enable ectogenesis did not exist, although forms of assisted reproduction, such as in vitro fertilization and intrauterine insemination, were starting to be developed. The Dialectic of Sex was one of the first feminist publications supporting ectogenesis, and, as of 2025, it continues to stimulate thinking among many researchers and ethicists who study the implications of new reproductive technologies for women.